IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Blood glucose sensor and transmitter ...

A new diabetes device may make tracking blood sugars and taking medication easier. The U.S. Food and Drug Administration said Tuesday that the Dexcom G5 continuous glucose monitoring system (CGM) can ...

The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system. Correction: A previous version of this article ...

The device includes a small sensor, placed just beneath the skin of my belly, and displays my blood glucose levels right on my Apple Watch. We all know about the market for wearable health trackers, ...

SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring for people with diabetes, announced today the U.S. Centers for Medicare & Medicaid Services (CMS) is ...

The t:slim X2™ Insulin Pump with Dexcom G5® Mobile continuous glucose monitoring (CGM) integration is the first sensor-augmented insulin pump approved to let users make treatment decisions without ...

The Centers for Medicare & Medicaid Services published criteria for coverage of therapeutic continuous glucose monitoring systems. Type 1 and Type 2 diabetes patients covered by Medicare who are on ...

Wearable fitness makers are increasingly interested in tracking our vitals. Now Fitbit has announced a collaboration with glucose monitor company Dexcom to develop and market products to help those ...

ORLANDO — In a head-to-head trial comparing three currently available continuous glucose monitors (CGMs) for real-world use in diabetes, the newly approved implantable glucose monitor Eversense ...

The markets seem to be happy with South San Francisco, CA-based DexCom, Inc.DXCM. The company's stock price rallied 4.8% to close at $82.62 yesterday following its announcement, that the Centers for ...

Dexcom’s biggest triumph and its biggest let down this quarter both involved the FDA. On the positive side, a verdict from a special FDA panel means Dexcom may soon be able to change its CGM’s ...